LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 265 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.06 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $226,000 | +12.4% | 1,658 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $201,000 | -57.8% | 1,658 | -64.6% | 0.00% | -75.0% |
Q4 2016 | $476,000 | +25.3% | 4,680 | +25.6% | 0.00% | +33.3% |
Q3 2016 | $380,000 | -25.3% | 3,726 | -12.7% | 0.00% | -25.0% |
Q2 2016 | $509,000 | -21.0% | 4,270 | -28.9% | 0.00% | -33.3% |
Q1 2016 | $644,000 | -2.3% | 6,009 | -1.1% | 0.01% | 0.0% |
Q4 2015 | $659,000 | +89.9% | 6,075 | +49.9% | 0.01% | +50.0% |
Q3 2015 | $347,000 | +69.3% | 4,054 | +99.8% | 0.00% | +100.0% |
Q2 2015 | $205,000 | -23.2% | 2,029 | -41.4% | 0.00% | -33.3% |
Q1 2015 | $267,000 | -21.5% | 3,464 | -45.7% | 0.00% | -25.0% |
Q4 2014 | $340,000 | +10.0% | 6,383 | -3.0% | 0.00% | 0.0% |
Q3 2014 | $309,000 | – | 6,583 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $6,891 | 2.63% |
VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |